Cargando…
A protocol for metabolic characterization of human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM)
Recent advances in human induced pluripotent stem cell-derived cardiomyocytes (iPSCM) field offer a novel platform for modeling cardiac metabolism, heart diseases drug candidates screening and cardiac toxicity assessments. These workflows require a fully functional characterization of iPSCMs. Here w...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046813/ https://www.ncbi.nlm.nih.gov/pubmed/32140435 http://dx.doi.org/10.1016/j.mex.2019.05.028 |
_version_ | 1783502029530857472 |
---|---|
author | House, Alisha Fatica, Erica Shah, Rohan Stergar, Jared Pearce, Ryan Sandlers, Yana |
author_facet | House, Alisha Fatica, Erica Shah, Rohan Stergar, Jared Pearce, Ryan Sandlers, Yana |
author_sort | House, Alisha |
collection | PubMed |
description | Recent advances in human induced pluripotent stem cell-derived cardiomyocytes (iPSCM) field offer a novel platform for modeling cardiac metabolism, heart diseases drug candidates screening and cardiac toxicity assessments. These workflows require a fully functional characterization of iPSCMs. Here we report a step by step protocol for iPSCM metabolic characterization. The described assays cover analysis of small metabolites involved in a vital metabolic pathways. |
format | Online Article Text |
id | pubmed-7046813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-70468132020-03-05 A protocol for metabolic characterization of human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) House, Alisha Fatica, Erica Shah, Rohan Stergar, Jared Pearce, Ryan Sandlers, Yana MethodsX Biochemistry, Genetics and Molecular Biology Recent advances in human induced pluripotent stem cell-derived cardiomyocytes (iPSCM) field offer a novel platform for modeling cardiac metabolism, heart diseases drug candidates screening and cardiac toxicity assessments. These workflows require a fully functional characterization of iPSCMs. Here we report a step by step protocol for iPSCM metabolic characterization. The described assays cover analysis of small metabolites involved in a vital metabolic pathways. Elsevier 2019-05-29 /pmc/articles/PMC7046813/ /pubmed/32140435 http://dx.doi.org/10.1016/j.mex.2019.05.028 Text en © 2019 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Biochemistry, Genetics and Molecular Biology House, Alisha Fatica, Erica Shah, Rohan Stergar, Jared Pearce, Ryan Sandlers, Yana A protocol for metabolic characterization of human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) |
title | A protocol for metabolic characterization of human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) |
title_full | A protocol for metabolic characterization of human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) |
title_fullStr | A protocol for metabolic characterization of human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) |
title_full_unstemmed | A protocol for metabolic characterization of human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) |
title_short | A protocol for metabolic characterization of human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) |
title_sort | protocol for metabolic characterization of human induced pluripotent stem cell-derived cardiomyocytes (ips-cm) |
topic | Biochemistry, Genetics and Molecular Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046813/ https://www.ncbi.nlm.nih.gov/pubmed/32140435 http://dx.doi.org/10.1016/j.mex.2019.05.028 |
work_keys_str_mv | AT housealisha aprotocolformetaboliccharacterizationofhumaninducedpluripotentstemcellderivedcardiomyocytesipscm AT faticaerica aprotocolformetaboliccharacterizationofhumaninducedpluripotentstemcellderivedcardiomyocytesipscm AT shahrohan aprotocolformetaboliccharacterizationofhumaninducedpluripotentstemcellderivedcardiomyocytesipscm AT stergarjared aprotocolformetaboliccharacterizationofhumaninducedpluripotentstemcellderivedcardiomyocytesipscm AT pearceryan aprotocolformetaboliccharacterizationofhumaninducedpluripotentstemcellderivedcardiomyocytesipscm AT sandlersyana aprotocolformetaboliccharacterizationofhumaninducedpluripotentstemcellderivedcardiomyocytesipscm AT housealisha protocolformetaboliccharacterizationofhumaninducedpluripotentstemcellderivedcardiomyocytesipscm AT faticaerica protocolformetaboliccharacterizationofhumaninducedpluripotentstemcellderivedcardiomyocytesipscm AT shahrohan protocolformetaboliccharacterizationofhumaninducedpluripotentstemcellderivedcardiomyocytesipscm AT stergarjared protocolformetaboliccharacterizationofhumaninducedpluripotentstemcellderivedcardiomyocytesipscm AT pearceryan protocolformetaboliccharacterizationofhumaninducedpluripotentstemcellderivedcardiomyocytesipscm AT sandlersyana protocolformetaboliccharacterizationofhumaninducedpluripotentstemcellderivedcardiomyocytesipscm |